Sinopharm Group Co. Ltd Financials

Market Capitalization HK$63.35 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	6.90
Forward PE	6.44
Price to Sales TTM	HK$0.11
Price to Book MRQ	HK$0.84
Enterprise to Revenue	0.28
Enterprise to EBITDA	7.29

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-03-31
Profit Margin	1.47%
Operating Margin	2.84%
Return on Assets TTM	3.08%
Return on Equity TTM	11.90%

Income Statement

Revenue TTM	HK$633,584,256,222
Revenue per Share TTM	HK$189.41
Quarterly Revenue Growth	-47.80%
Gross Profit TTM	HK$50,640,165,940
EBITDA	HK$28,329,036,000
Net Income to Common TTM	HK$9,286,973,690
Diluted EPS TTM	HK$2.94
Quarterly Earnings Growth YoY	-50.50%

Balance Sheet

Total Cash MRQ	HK$46,506,062,759
Total Cash per Share MRQ	HK$13.89
Total Debt MRQ	HK$
Total Debt to Equity MRQ	82.54
Current Ratio MRQ	1.35
Book Value per Share MRQ	HK$24.21

Cash Flow

Operating Cash Flow TTM	HK$20,934,429,722
Levered Free Cash Flow TTM	HK$9,463,001,588

1099 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,341,810,048
Float Shares	1,341,663,716
Avg 10 Volume	3,787,135
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.01%
% Held by Institutions	70.40%

Stock Price Summary

Beta	0.86
Fifty Two Week Low	HK$16.02
Fifty Two Week High	HK$23.65
Fifty Two Week Change	-2.49%
Day 50 MA	HK$20.85
Day 200 MA	HK$20.14

Dividends and Splits

Forward Annual Dividend Rate	HK$3.82
Forward Annual Dividend Yield	19.02%
Trailing Annual Dividend Rate	HK$0.96
Trailing Annual Dividend Yield	4.76%
Payout Ratio	32.12%
Dividend Date
Ex Dividend Date	2024-06-17
Last Split Factor
Last Split Date